AI assistant
SINGULAR HEALTH GROUP LTD — Proxy Solicitation & Information Statement 2025
Feb 16, 2025
65786_rns_2025-02-16_82e74c9a-bd1f-47e1-a5da-f7c02c06a8e6.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
==> picture [595 x 115] intentionally omitted <==
Singular Health Group Ltd: SHG
17 February 2025
GENERAL MEETING
Singular Health Group Ltd (ASX: SHG, “Singular Health”, or the “Company”), advises that a General Meeting of the Company will be held in person at Automic Group, Level 5, 191 St Georges Terrace, Perth, Western Australia on Wednesday 19 March 2025 at 10.00am (AWST) (Meeting).
Notice of Meeting
The Notice of Meeting and Explanatory Memorandum (Notice) for the Meeting is available online and can be viewed and downloaded by shareholders of the Company (Shareholders) from Singular Health’s website at https://singular.health/ or the Company's ASX market announcements platform at www.asx.com.au (ASX: SHG).
In accordance with section 110D of the Corporations Act 2001 (Cth) (Corporations Act), the Company will not be sending hard copies of the Notice of Meeting to Shareholders, unless a shareholder has requested a hard copy of the Notice of Meeting or made an election for the purposes of section 110E of the Corporations Act to receive documents from the Company in physical form. If you have any difficulties obtaining a copy of the Notice, please contact the Company’s Share Registry, Automic Registry Services, at [email protected].
Proxy Form
A Proxy Form in relation to the Meeting is included with this letter. Voting on the resolutions at the Meeting is important and Shareholders who are unable to attend the Meeting in person are encouraged to exercise their voting rights by completing and returning the enclosed Proxy Form. Please refer to the full Notice for further important information.
Completed proxy forms must be returned to and received by the Company’s Share Registry, Automic Registry Services, by 10.00am (AWST) on Monday 17 March 2025, by following the lodgement instructions on the proxy form.
Shareholder queries in relation to the Meeting
Shareholders can contact the Company Secretary with any questions prior to the meeting on +61 2 9299 9690 between 8:30am and 5:00pm (AWST) Monday to Friday or via email at [email protected].
Copies of all Meeting related material including the Notice, are available to download from Singular Health’s website and the Company's ASX market announcements platform.
In the event it is necessary or appropriate for the Company to make alternative arrangements for the Meeting, information will be provided to Shareholders via the ASX and Singular Health’s website.
This announcement is authorised for release by the Board of Directors for the Company.
For further information contact:
Denning Chong Managing Director & CEO [email protected] 1300 167 795
Paul Berson Investor Relations [email protected] +61 421 647 445
==> picture [596 x 74] intentionally omitted <==